Moore Capital Management, LP Teva Pharmaceutical Industries LTD Transaction History

Moore Capital Management, LP

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $8.93 Million - $14.4 Million	-1,100,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$6.69 - $13.45 $7.36 Million - $14.8 Million	1,100,000 New	1,100,000 $9.88 Million

604

567M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Moore Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Moore Capital Management, LP with notifications on news.